Ausgabe 11/2021
Inhalt (28 Artikel)
TARP as antigen in cancer immunotherapy
Jolien Vanhooren, Charlotte Derpoorter, Barbara Depreter, Larissa Deneweth, Jan Philippé, Barbara De Moerloose, Tim Lammens
Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis
E. Suazo-Zepeda, M. Bokern, P. C. Vinke, T. J. N. Hiltermann, G. H. de Bock, G. Sidorenkov
Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients
Takeshi Ishikawa, Shinichi Kageyama, Yoshihiro Miyahara, Tetsuya Okayama, Satoshi Kokura, Linan Wang, Eiichi Sato, Hideo Yagita, Yoshito Itoh, Hiroshi Shiku
Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine
Kyp L. Oxley, Brett M. Hanson, Ashley N. Zani, Gail A. Bishop
Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area
Gregory R. Stroh, Tobias Peikert, Patricio Escalante
Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer
Won Ik Seo, Chan Ho Lee, Soo Jin Jung, Dae Sim Lee, Ha Young Park, Dae Hoon Jeong, Wansuk Kim, Jae Il Chung, Inhak Choi
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy
Danielle Verver, Dirk J. Grünhagen, Alexander C. J. van Akkooi, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Marye J. Boers-Sonderen, John B. A. G. Haanen, Geke A. P. Hospers, Ellen Kapiteijn, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Albert J.ten Tije, Gerard Vreugdenhil, Cornelis Verhoef, Astrid A. M. van der Veldt
Distinct genomic features across cytolytic subgroups in skin melanoma
Constantinos Roufas, Ilias Georgakopoulos-Soares, Apostolos Zaravinos
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
Kristina Witt, Susan Evans-Axelsson, Andreas Lundqvist, Martin Johansson, Anders Bjartell, Rebecka Hellsten
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses
Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir, Denise Vodegel, Inge Hermens, Anniek B. van der Waart, J. H. Frederik Falkenburg, Michel G. D. Kester, Iris de Rink, Mirjam H. M. Heemskerk, Jannie Borst, Nicolaas P. M. Schaap, Joop H. Jansen, Yanling Xiao, Harry Dolstra, Willemijn Hobo
Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen
Marco Stringhini, Ilaria Spadafora, Marco Catalano, Jacqueline Mock, Philipp Probst, Roman Spörri, Dario Neri
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab
Wei-Xiang Qi, Yi Xiang, Shengguang Zhao, Jiayi Chen
Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis
Min-Ke He, Chuan Peng, Yang Zhao, Run-Bin Liang, Zhi-Cheng Lai, Anna Kan, Qi-Jiong Li, Wei Wei, Yao-Jun Zhang, Min-Shan Chen, Rong-Ping Guo, Ming Shi
Enhancement of innate and adaptive anti-tumor immunity by serum obtained from vascular photodynamic therapy-cured BALB/c mouse
Ying Zhang, Ying-Kit Cheung, Dennis K. P. Ng, Wing-Ping Fong
CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer
Xuehui Wu, Xiaoliang Lan, Wanming Hu, Wanning Zhang, Xiangmeng Lai, Shaowan Xu, Jiaoying Li, Weihao Qiu, Wei Wang, Jianbiao Xiao, Feifei Wang, Yanqing Ding, Li Liang
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
Vanessa S. Fear, Catherine A. Forbes, Samuel A. Neeve, Scott A. Fisher, Jonathan Chee, Jason Waithman, Shao Kang Ma, Richard Lake, Anna K. Nowak, Jenette Creaney, Matthew D. Brown, Christobel Saunders, Bruce W. S. Robinson
Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
Vanessa S. Fear, Catherine A. Forbes, Samuel A. Neeve, Scott A. Fisher, Jonathan Chee, Jason Waithman, Shao Kang Ma, Richard Lake, Anna K. Nowak, Jenette Creaney, Matthew D. Brown, Christobel Saunders, Bruce W. S. Robinson
RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation
Pingfeng Chen, Youjun Duan, Xinsheng Lu, Libo Chen, Wang Zhang, Hao Wang, Rong Hu, Shimin Liu
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program
Javier Arranz-Nicolás, Miguel Martin-Salgado, Irene Adán-Barrientos, Rosa Liébana, María del Carmen Moreno-Ortíz, Judith Leitner, Peter Steinberger, Antonia Ávila-Flores, Isabel Merida
Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigens
Junxia Gao, Xianlin Yuan, Jia Yuan, Liangping Li
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations
Ondrej Uher, Veronika Caisova, Lucie Padoukova, Karolina Kvardova, Kamila Masakova, Radka Lencova, Andrea Frejlachova, Marketa Skalickova, Anna Venhauerova, Adela Chlastakova, Per Hansen, Jindrich Chmelar, Jan Kopecky, Zhengping Zhuang, Karel Pacak, Jan Zenka
Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study
H. M. Stege, M. Haist, S. Schultheis, M. I. Fleischer, P. Mohr, S. Ugurel, P. Terheyden, A. Thiem, F. Kiecker, U. Leiter, J. C. Becker, M. Meissner, J. Kleeman, C. Pföhler, J. Hassel, S. Grabbe, C. Loquai
Identification of mouse helper epitopes for WT1-specific CD4+ T cells
Hiroko Nakajima, Jun Nakata, Kanako Imafuku, Hiromu Hayashibara, Kazuki Isokawa, Keiko Udaka, Fumihiro Fujiki, Soyoko Morimoto, Kana Hasegawa, Naoki Hosen, Yoshiko Hashii, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Shinji Sogo, Haruo Sugiyama
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
Cameron J. Herting, Matthew R. Farren, Yan Tong, Ziyue Liu, Bert O’Neil, Tanios Bekaii-Saab, Anne Noonan, Christopher McQuinn, Thomas A. Mace, Walid Shaib, Christina Wu, Bassel F. El-Rayes, Safi Shahda, Gregory B. Lesinski
Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma
Beatrice Dozin, Grazia Carbotti, Silvio Roncella, Paola Ferro, Paolo Dessanti, Pier Aldo Canessa, Silvano Ferrini, Marina Fabbi
Immune checkpoint inhibitors-induced nephropathy: a French national survey
Alexandre O. Gérard, Marine Andreani, Audrey Fresse, Nadège Parassol, Marine Muzzone, Sylvine Pinel, Delphine Bourneau-Martin, Delphine Borchiellini, Fanny Rocher, Vincent L. M. Esnault, Milou-Daniel Drici
Correction to: Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer
Łukasz Zadka, Mariusz Chabowski, Damian Grybowski, Aleksandra Piotrowska, Piotr Dzięgiel
Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells
J. M. R. Van der Meer, R. J. A. Maas, K. Guldevall, K. Klarenaar, P. K. J. D. De Jonge, J. S. Hoogstad-van Evert, A. B. van der Waart, J. Cany, J. T. Safrit, J. H. Lee, E. Wagena, P. Friedl, B. Önfelt, L. F. Massuger, N. P. M. Schaap, J. H. Jansen, W. Hobo, H. Dolstra